Delivery Order SPE2DB25D3404-SPE2DB25FUNCA
Award Date
4/23/25
Potential Completion Date
5/14/25
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PROQUAD VIALS, a medical product, with a ceiling value of $1,687.48 and a performance period ending on July 23, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PROQUAD VIALS, a type of pharmaceutical product. The contract has a ceiling value of $8,271.65 and a completion date of July 23, 2025. It is a firm-fixed-price delivery order contract, without any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROQUAD VIALS, a pharmaceutical product, with a ceiling value of $5,062.44 and a period of performance through July 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROQUAD VIALS, a pharmaceutical product, with a ceiling value of $8,271.65 and a period of performance through June 20, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROQUAD VIALS, a type of pharmaceutical product, with a ceiling value of $8,354.50 and a period of performance through June 5, 2025. The contract is a Firm Fixed Price, Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROQUAD VIALS, a medical product, with a Ceiling Value of $1,687.48 and a completion date of June 13, 2025. The contract is a Firm Fixed Price type and is not set aside for any particular business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROQUAD VIALS, a medical product, with a ceiling value of $3,374.96 and a period of performance ending on July 18, 2025. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROQUAD VIALS, a medical product, with a ceiling value of $2,740.49 and a completion date of June 6, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of PROQUAD VIALS, a pharmaceutical product. The contract has a ceiling value of $1,687.48 and a period of performance through May 16, 2025. The contract is a firm fixed-price delivery order, which indicates a pre-existing contract vehicle. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply PROQUAD VIALS. The contract has a ceiling value of $2,713.46 and is a firm fixed-price type with a period of performance through July 16, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...